FDA Orders New Warning Labels on Opioids
FDA updates opioid labels to highlight overdose risks and long-term dangers.
Sara E. Teller
Sara is a credited writer, editor, contributor, and essayist, as well as a novelist and poet with more than two decades of experience in media arts. A seasoned publishing professional, she's worked for newspapers, magazines and book publishers in content digitization, editorial, acquisitions and intellectual property. Sara is a member of the International Association of Writers & Editors, has received numerous awards and has been an invited speaker at a Careers in Publishing & Authorship event at Michigan State University and a Reading and Writing Instructor at Sylvan Learning Center. She is also a mental health therapist, clinical supervisor and entrepreneur, holding an MBA degree with a concentration in Marketing and an MA in Clinical Mental Health Counseling (graduating with a 4.2/4.0 GPA). Additionally, she is a member of Chi Sigma Iota, was on her local chapter's board, and a 2020 recipient of the Donald D. Davis scholarship recognizing social responsibility. Sara is certified in children's book writing, HTML coding and social media marketing. Her nine books can be found on Amazon.
Asthma Drug Shows Promise for Food Allergies
Asthma medication blocked severe allergic reactions to peanuts in mouse study.
Toddler Death Prompts Play Kitchen Recall
Hook on toy kitchen led to toddler’s death, triggering nationwide recall.
Patients Report Injuries After Cosmetic Surgeries
Patients allege painful injuries and poor oversight at fast-growing cosmetic surgery chains.
Opioid System Linked to Ketamine’s Antidepressant Effects
Blocking opioid receptors reduced ketamine’s brain activity and mood benefits.
Kansas City Settles Lawsuit With Former Official
Former city official receives settlement after claims of mistreatment and demotion.
Maryland Schools Sue Social Media Giants
Six school districts sue social media companies over impact on student mental health.
FDA Expert Panels Bypass Standard Protocols
FDA’s new expert panels raise concerns over transparency, bias, and legal process.
FDA Warns Glenmark Pharmaceuticals Over Drug Safety
Delayed testing and factory issues have led to dangerous pills and patient deaths.
Dentists Concerned After Delta Dental Acquisition
Wisconsin dentists raise concerns over business influence on patient care decisions.